1,054 Shares in CME Group Inc. (NASDAQ:CME) Purchased by Fielder Capital Group LLC

Fielder Capital Group LLC purchased a new stake in shares of CME Group Inc. (NASDAQ:CME) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,054 shares of the financial services provider’s stock, valued at approximately $222,000.

Other hedge funds have also recently bought and sold shares of the company. Morgan Stanley grew its holdings in CME Group by 31.5% during the third quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider’s stock worth $972,863,000 after purchasing an additional 1,163,103 shares during the period. FMR LLC boosted its stake in shares of CME Group by 1.8% during the 3rd quarter. FMR LLC now owns 4,029,771 shares of the financial services provider’s stock worth $806,841,000 after acquiring an additional 70,588 shares during the period. Northern Trust Corp increased its holdings in shares of CME Group by 4.9% during the 3rd quarter. Northern Trust Corp now owns 3,668,138 shares of the financial services provider’s stock worth $734,435,000 after acquiring an additional 172,264 shares during the last quarter. Ameriprise Financial Inc. raised its stake in CME Group by 3.6% in the 3rd quarter. Ameriprise Financial Inc. now owns 3,579,057 shares of the financial services provider’s stock valued at $716,604,000 after acquiring an additional 125,263 shares during the period. Finally, Invesco Ltd. lifted its holdings in CME Group by 6.7% during the 3rd quarter. Invesco Ltd. now owns 3,465,422 shares of the financial services provider’s stock valued at $693,847,000 after purchasing an additional 217,101 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Price Performance

NASDAQ CME traded up $0.35 on Monday, hitting $208.00. 1,722,488 shares of the company’s stock were exchanged, compared to its average volume of 1,783,085. CME Group Inc. has a 52 week low of $175.73 and a 52 week high of $223.80. The stock has a 50-day moving average of $213.87 and a 200-day moving average of $211.45. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a market cap of $74.88 billion, a price-to-earnings ratio of 23.66, a P/E/G ratio of 5.19 and a beta of 0.48.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. The firm had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.42 earnings per share. Analysts expect that CME Group Inc. will post 9.72 earnings per share for the current year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Investors of record on Friday, March 8th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.60 dividend on an annualized basis and a yield of 2.21%. This is a positive change from CME Group’s previous quarterly dividend of $1.10. CME Group’s payout ratio is currently 52.33%.

Wall Street Analyst Weigh In

CME has been the topic of a number of recent research reports. Bank of America increased their target price on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a research note on Thursday, April 25th. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research report on Thursday, April 25th. Rosenblatt Securities restated a “sell” rating and issued a $187.00 price target (up from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Barclays increased their target price on shares of CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 25th. Finally, Morgan Stanley lifted their price target on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $217.80.

Insiders Place Their Bets

In other news, CEO Terrence A. Duffy sold 40,000 shares of the company’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $210.91, for a total value of $8,436,400.00. Following the completion of the transaction, the chief executive officer now owns 67,455 shares of the company’s stock, valued at $14,226,934.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.